Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration

Donald R. Jasinski, John Nutt, John D. Griffith

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The effects of diethylpropion were determined and compared with those of d-amphetamine in 9 subjects using a crossover design. Diethylpropion produced effects qualitatively similar to those of d-amphetamine, but significantly less potent. Orally diethylpropion was 1 6 to 1 11 as potent as d-amphetamine while subcutaneously diethylpropion was 1 10 to 1 20 as potent as d-amphetamine. A striking difference between diethylpropion and d-amphetamine was the relatively greater oral efficacy of diethylpropion. Diethylpropion was twice as potent orally as subcutaneously while oral and subcutaneous d-amphetamine were equipotent.

Original languageEnglish (US)
Pages (from-to)645-652
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume16
Issue number4
StatePublished - Oct 1974
Externally publishedYes

Fingerprint

Diethylpropion
Dextroamphetamine
Oral Administration
Cross-Over Studies

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration. / Jasinski, Donald R.; Nutt, John; Griffith, John D.

In: Clinical Pharmacology and Therapeutics, Vol. 16, No. 4, 10.1974, p. 645-652.

Research output: Contribution to journalArticle

@article{74ed2c010a1c4447b9eeaa1af5a1500c,
title = "Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration",
abstract = "The effects of diethylpropion were determined and compared with those of d-amphetamine in 9 subjects using a crossover design. Diethylpropion produced effects qualitatively similar to those of d-amphetamine, but significantly less potent. Orally diethylpropion was 1 6 to 1 11 as potent as d-amphetamine while subcutaneously diethylpropion was 1 10 to 1 20 as potent as d-amphetamine. A striking difference between diethylpropion and d-amphetamine was the relatively greater oral efficacy of diethylpropion. Diethylpropion was twice as potent orally as subcutaneously while oral and subcutaneous d-amphetamine were equipotent.",
author = "Jasinski, {Donald R.} and John Nutt and Griffith, {John D.}",
year = "1974",
month = "10",
language = "English (US)",
volume = "16",
pages = "645--652",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration

AU - Jasinski, Donald R.

AU - Nutt, John

AU - Griffith, John D.

PY - 1974/10

Y1 - 1974/10

N2 - The effects of diethylpropion were determined and compared with those of d-amphetamine in 9 subjects using a crossover design. Diethylpropion produced effects qualitatively similar to those of d-amphetamine, but significantly less potent. Orally diethylpropion was 1 6 to 1 11 as potent as d-amphetamine while subcutaneously diethylpropion was 1 10 to 1 20 as potent as d-amphetamine. A striking difference between diethylpropion and d-amphetamine was the relatively greater oral efficacy of diethylpropion. Diethylpropion was twice as potent orally as subcutaneously while oral and subcutaneous d-amphetamine were equipotent.

AB - The effects of diethylpropion were determined and compared with those of d-amphetamine in 9 subjects using a crossover design. Diethylpropion produced effects qualitatively similar to those of d-amphetamine, but significantly less potent. Orally diethylpropion was 1 6 to 1 11 as potent as d-amphetamine while subcutaneously diethylpropion was 1 10 to 1 20 as potent as d-amphetamine. A striking difference between diethylpropion and d-amphetamine was the relatively greater oral efficacy of diethylpropion. Diethylpropion was twice as potent orally as subcutaneously while oral and subcutaneous d-amphetamine were equipotent.

UR - http://www.scopus.com/inward/record.url?scp=0016215874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016215874&partnerID=8YFLogxK

M3 - Article

C2 - 4607788

AN - SCOPUS:0016215874

VL - 16

SP - 645

EP - 652

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -